Aldesleukin Completed Phase 2 Trials for Cancer, Anal / Oropharyngeal Cancers / Cervical Cancers / Penile Cancer / Vaginal Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01585428Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers
NCT02280811T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers